JakartaPost-Dec 9, 2024
A t least three Indian pharmaceutical companies are eyeing investment opportunities in Indonesia, according to Indian Ambassador to Indonesia Sandeep Chakravorty. He said companies like MSN Laboratories and Dr. Reddy’s Laboratories are on the list. “In India, we have a huge program called Jan Aushadhi, where medicines are available at rock-bottom prices to the poor and to everybody. We want to see if the model can be implemented in Indonesia,” Chakravorty said at the India-Indonesia Investment Synergy Forum on Friday. The diplomat also noted collaboration between Indian and Indonesian healthcare providers, citing India’s Apollo Hospitals and Artemis Hospitals forging partnerships with local counterparts. In October, then-president Joko “Jokowi” Widodo established a special economic zone (SEZ) for tourism and health in Batam, with Apollo Hospitals and local hospital operator Mayapada Healthcare as the main investors. The two companies plan to collaborate to construct the Mayapada Apollo Batam International Hospital, which is set to begin operations in 2026. Meanwhile, the Artemis Hospital signed a memorandum of understanding (MoU) with local healthcare provider Abdi Waluyo Hospital on Nov. 20. The agreement includes clinical partnerships, knowledge exchange and nurse training programs and also allows Abdi Waluyo to bring in doctors from India to handle complex medical cases. Read more at:
